Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

NCT03338920 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
159
Enrollment
INDUSTRY
Sponsor class

Stopped eDiary data collected not sufficient to utilize in the analysis of protocol endpoints

Conditions

Interventions

Sponsor

Currax Pharmaceuticals